Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elysa M Wolf

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|September 19, 2022
The therapeutic potential of TREM2 in cancerElysa M Wolf, Barbara Fingleton, Alyssa H Hasty
The Journal of Physiology|August 31, 2022
Exon 2-mediated deletion of Trem2 does not worsen metabolic function in diet-induced obese miceNathan C Winn, Elysa M Wolf, Jamie N Garcia, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 2, 2021
Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult miceNathan C Winn, Elysa M Wolf, Matthew A Cottam, et al.
Journal of Inorganic Biochemistry|September 18, 2017
Protein oxidation involved in Cys-Tyr post-translational modificationSusan E Hromada, Adam M Hilbrands, Elysa M Wolf, et al.
The Journal of Pathology. Clinical Research|February 18, 2021
A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancerAmanda B Hesterberg, Brenda L Rios, Elysa M Wolf, et al.
Molecular Metabolism|October 9, 2021
Pharmacological blockade of the EP3 prostaglandin E<sub>2</sub> receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damageKarin J Bosma, Spencer R Andrei, Liora S Katz, et al.
Nature|June 12, 2024
Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Nature|July 9, 2024
Author Correction: Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|September 19, 2022
The therapeutic potential of TREM2 in cancerElysa M Wolf, Barbara Fingleton, Alyssa H Hasty
The Journal of Physiology|August 31, 2022
Exon 2-mediated deletion of Trem2 does not worsen metabolic function in diet-induced obese miceNathan C Winn, Elysa M Wolf, Jamie N Garcia, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 2, 2021
Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult miceNathan C Winn, Elysa M Wolf, Matthew A Cottam, et al.
Journal of Inorganic Biochemistry|September 18, 2017
Protein oxidation involved in Cys-Tyr post-translational modificationSusan E Hromada, Adam M Hilbrands, Elysa M Wolf, et al.
The Journal of Pathology. Clinical Research|February 18, 2021
A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancerAmanda B Hesterberg, Brenda L Rios, Elysa M Wolf, et al.
Molecular Metabolism|October 9, 2021
Pharmacological blockade of the EP3 prostaglandin E<sub>2</sub> receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damageKarin J Bosma, Spencer R Andrei, Liora S Katz, et al.
Nature|June 12, 2024
Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Nature|July 9, 2024
Author Correction: Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Pageof 1